Cardiocomm Solutions Inc.

CardioComm Solutions is a Toronto-based medical technology provider specializing in electrocardiogram (ECG) acquisition, management software, and remote cardiac monitoring solutions. The company serves both healthcare professionals and consumer markets with FDA-approved and Health Canada-cleared GEMS™ software platform, which has processed over 10 million ECG recordings.

The company's product portfolio includes ambulatory cardiac long-term continuous monitoring (LTCM) systems for healthcare providers and HeartCheck™ personal ECG monitors for consumers. Their GEMS™ mobile app enables patients to analyze and report ECGs with rapid SMART Monitoring ECG reading services providing review within 30 minutes. CardioComm has expanded beyond cardiac monitoring into multiple bio-sign monitoring through their Body-by-GEMS (BBG) software, which serves as a central hub for collecting and analyzing data from various medical devices, sensors, and wearables.

With over two decades of experience in remote patient health monitoring, CardioComm Solutions operates as a publicly-traded company on the TSX Venture Exchange (ticker: EKG). The company maintains regulatory clearances from both U.S. and Canadian health authorities for their medical-grade monitoring devices.

CardioComm Solutions is appropriate for organizations prioritizing regulatory-cleared, proven cardiac monitoring technology with a substantial track record. Their combination of professional-grade and consumer-facing solutions allows healthcare systems to extend monitoring capabilities beyond traditional clinical settings.

Expect a focused partnership centered on ECG and cardiac monitoring expertise rather than broad healthcare IT services. The company's dual-market approach enables programs that span clinical care and patient-directed monitoring, with the added benefit of rapid professional ECG interpretation services.

CardioComm Solutions operates exclusively in healthcare with specific focus on cardiology and remote patient monitoring. Their GEMS™ software and HeartCheck™ devices maintain FDA approval and Health Canada clearance, addressing regulatory requirements for medical device software. The company specializes in cardiac care delivery across hospitals, health systems, and direct-to-consumer channels.

Their solutions specifically address telemedicine and remote monitoring needs in cardiology, with established workflows for ambulatory ECG monitoring, long-term continuous monitoring, and rapid professional ECG interpretation services. The company's expertise extends to integrating multiple bio-signs for comprehensive remote patient monitoring programs.

Healthcare systems implementing or expanding remote cardiac monitoring programs, cardiology practices seeking ambulatory monitoring solutions, and telemedicine providers requiring medical-grade ECG capabilities. Consumer health companies and retailers looking for regulatory-cleared, easy-to-use heart monitoring devices. Organizations in North America prioritizing established regulatory compliance for cardiac monitoring technology.